3863 results for «596»
3863 results
Hotline TAVI 1: extended analysis of the randomised trials
21 May 2025 – From EuroPCR 2025
Gain comprehensive insights from extended analyses of randomized TAVI trials. This session reviews five-year UK TAVI outcomes, cardiac damage evolution in asymptomatic aortic stenosis, one-year results from the LANDMARK trial, and three-year comparisons of balloon-expandable valves, highlighting critical clinical implications.
Through decisions in complex left main PCI - Isolated ostial left circumflex
21 May 2025 – From EuroPCR 2025
Navigate complex isolated ostial left circumflex lesions with a focus on the integration of imaging and physiological assessment. Learn treatment options and optimisation strategies to improve long-term outcomes in left main PCI through detailed case presentations and expert guidance.
How to avoid and manage complications in CTO interventions
21 May 2025 – From EuroPCR 2025
Learn how to anticipate, prevent, and manage complications during complex CTO interventions. This session presents real-world cases including donor artery dissection, main and distal vessel perforations, and the importance of teamwork in the cath lab for successful complication management.
DCB PCI: are we ready for complex de novo lesions?
21 May 2025 – From EuroPCR 2025
Evaluate the readiness of drug-coated balloon (DCB) therapy for complex de novo coronary lesions. This session reviews comparative outcomes of DCB versus drug-eluting stents (DES) across CHIP risk categories, impacts of diabetes, long-term follow-up data in calcified lesions and left main bifurcations, and treatment of in-stent...
Management of high-risk left main lesion
21 May 2025 – From EuroPCR 2025
Focus on managing high-risk left main coronary lesions with this session featuring complex cases such as thrombotic lesions, calcified distal left main PCI with orbital atherectomy and IVUS guidance, and advanced stenting techniques. Learn practical approaches for challenging anatomical and clinical scenarios to optimize patient outcomes.
Did danger shock change my practice?
21 May 2025 – From EuroPCR 2025
Reflect on how contemporary management of cardiogenic shock has evolved through this session. Review collaborative strategies, challenging clinical cases involving STEMI, multivessel disease, refractory shock, spontaneous coronary artery dissection, and the critical role of intracoronary imaging in guiding interventional decisions.
Antithrombotic drugs for acute coronary syndromes in women
21 May 2025 – From EuroPCR 2025
Enhance your understanding of antithrombotic drug management in women with acute coronary syndromes (ACS). This session addresses risk stratification balancing ischemic and bleeding risks, evidence-based tailored antithrombotic and revascularisation strategies in high bleeding risk patients, and diagnostic and treatment approaches for MINOCA, with illustrative cases highlighting...
Strategies in treating double CTO scenarios
21 May 2025 – From EuroPCR 2025
Navigate complex double chronic total occlusion (CTO) scenarios with this session that emphasizes thorough lesion qualification and innovative techniques. Learn strategies including management of ambiguous proximal caps, sequential vessel revascularization, and advanced tools like snaring and deflection to optimize procedural success.
TAVI for aortic regurgitation: off-label use
21 May 2025 – From EuroPCR 2025
Explore the complexities and off-label challenges of transcatheter aortic valve implantation (TAVI) in patients with severe pure aortic regurgitation. This session highlights the bold strategies, complication management, and innovative use of the Octacor valve in this demanding clinical scenario, providing valuable insights into navigating a difficult...
Unconventional situations and complications during cardiovascular interventions
21 May 2025 – From EuroPCR 2025
Explore this session to gain expert tips and practical strategies for managing unexpected complications during cardiovascular interventions. Learn how to anticipate and avoid complications in conventional procedures and discover different approaches to tackle challenging situations in the cathlab through detailed case discussions involving PCI, TAVI, and...
Large thrombus burden: contemporary solutions
21 May 2025 – From EuroPCR 2025
This session presents contemporary strategies for managing large thrombus burden in STEMI patients. Learn from expert cases demonstrating multiple effective approaches including modified manual thrombus aspiration guided by intravascular ultrasound (IVUS) and streamlined primary PCI techniques, essential for optimizing outcomes in complex thrombotic scenarios.
How complex left main intervention can be?
21 May 2025 – From EuroPCR 2025
Stay updated on the complexities of left main coronary artery interventions with this comprehensive session. Delve into the latest guidelines and trial data for 2025, understand the meticulous preparation and advanced techniques involved, and examine potential adverse effects and complications through real-world complex case scenarios.
DCB in challenging scenarios - Part 1
21 May 2025 – From EuroPCR 2025
Discover the expanding role of drug-coated balloons (DCB) in challenging coronary interventions. This session covers their application in acute coronary syndrome complications, complex coronary artery disease revascularization, and in-stent restenosis at left main bifurcations, highlighting innovative combinations with drug-eluting stents for managing complex bifurcation and trifurcation...
Updates in transcatheter MVR
21 May 2025 – From EuroPCR 2025
This session provides a detailed overview of recent advances in transcatheter mitral valve replacement (TMVR). Examine outcomes from next-generation transcatheter heart valves, long-term clinical data from mitral valve-in-valve and valve-in-ring procedures, and explore innovative approaches including transseptal MVR with insights from global studies.
Interventional approaches for cardiogenic shock
21 May 2025 – From EuroPCR 2025
Gain comprehensive insights into interventional strategies for cardiogenic shock, including management of non-ischemic etiologies, innovative use of ventricular vents with ECMO, the interplay of Impella, PCI, and MitraClip, and bridging techniques using left atrial veno-arterial ECMO in severe valve disease and biventricular failure.
Paravalvular leak closure: challenges and percutaneous solutions
21 May 2025 – From EuroPCR 2025
This session addresses the challenges and percutaneous techniques for paravalvular leak closure following valve replacement. Through complex case studies, it explores managing unexpected anatomical defects, dealing with failed closure attempts, and strategies in malpositioned valves, providing practical guidance for successful intervention in difficult scenarios.
Cathlab harmony: building high-performance teams
21 May 2025 – From EuroPCR 2025
Discover strategies to build and maintain high-performance teams in the cathlab environment. This session outlines how to foster a collaborative culture, address toxic behaviors, and effectively train and integrate team members to enhance teamwork and procedural success in cardiovascular interventions.
Imaging-guided management of PCI pitfalls in NSTEMI
21 May 2025 – From EuroPCR 2025
Dive into the imaging-guided management of PCI pitfalls in NSTEMI patients. This session highlights critical cases such as complications from missed PCI, crushed stents, multiple coronary lumens, and migrating thrombus, emphasizing the role of advanced intracoronary imaging for precise diagnosis and optimized interventional outcomes.
DES and bioadaptator technologies in contemporary practice
21 May 2025 – From EuroPCR 2025
Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...
Management of non-culprit lesions in patients with ACS and multivessel disease
21 May 2025 – From EuroPCR 2025
This session addresses the optimal management of non-culprit lesions (NCL) in patients with acute coronary syndrome (ACS) and multivessel disease. Learn about angiography, imaging, and FFR-guided strategies, timing considerations for PCI in high-risk NSTEMI patients, and patient selection for early staged PCI post-STEMI through detailed case...
